Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Ewing Sarcoma

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	dactinomycin Sensitive: A1 - Approval dactinomycin Sensitive : A1	dactinomycin Sensitive: A1 - Approval dactinomycin Sensitive : A1
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	Sensitive: A2 - Guideline Sensitive : A2	Sensitive: A2 - Guideline Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	melphalan + busulfan Sensitive: A2 - Guideline melphalan + busulfan Sensitive : A2	melphalan + busulfan Sensitive: A2 - Guideline melphalan + busulfan Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2	cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive: A2 - Guideline cyclophosphamide + ifosfamide + etoposide IV + topotecan Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	temozolomide + irinotecan Sensitive: A2 - Guideline temozolomide + irinotecan Sensitive : A2	temozolomide + irinotecan Sensitive: A2 - Guideline temozolomide + irinotecan Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	cyclophosphamide + topotecan Sensitive: A2 - Guideline cyclophosphamide + topotecan Sensitive : A2	cyclophosphamide + topotecan Sensitive: A2 - Guideline cyclophosphamide + topotecan Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2	carboplatin + ifosfamide + etoposide IV Sensitive: A2 - Guideline carboplatin + ifosfamide + etoposide IV Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	gemcitabine + docetaxel Sensitive: A2 - Guideline gemcitabine + docetaxel Sensitive : A2	gemcitabine + docetaxel Sensitive: A2 - Guideline gemcitabine + docetaxel Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	cabozantinib tablet Sensitive: A2 - Guideline cabozantinib tablet Sensitive : A2	cabozantinib tablet Sensitive: A2 - Guideline cabozantinib tablet Sensitive : A2